HXBM OTC
Helix BioMedix, Inc.
1W: -34.2%
1M: -45.2%
3M: +83.8%
YTD: +64.5%
1Y: -6.0%
3Y: -85.0%
5Y: -86.9%
$3.29
-1.11 (-25.28%)
Weekly Expected Move ±43.7%
$0
$2
$3
$5
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$601K
+0.0% ▲
Capital Expenditures
$3
+0.0% ▲
5Y CAGR: -74.3%
Free Cash Flow
-$601K
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$601K
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$1M | -$1M | -$1M | -$552K |
| Depreciation & Amort. | $8K | $13K | $13K | $10K | $5K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $434K | $146K | -$788 | -$106K | -$61K |
| Other Non-Cash Items | $745K | $347K | $452K | $282K | $6K |
| Operating Cash Flow | -$667K | -$855K | -$728K | -$870K | -$601K |
| — Investing Activities — | |||||
| Capital Expenditures | -$41K | -$8K | -$1K | -$1K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $8K | $0 |
| Investment Purchases | $0 | -$3M | $0 | $0 | $0 |
| Investment Sales | $0 | $3M | $1M | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$41K | -$257K | $1M | $6K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $140K | $152K | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $140K | $152K | $0 | $0 | $0 |
| Net Change in Cash | -$568K | -$2M | $521K | -$864K | -$601K |
| Cash End of Period | $5M | $3M | $3M | $3M | $1M |
| Free Cash Flow | -$708K | -$862K | -$729K | -$872K | -$601K |